Long-term statin therapy and CSF cholesterol levels: Implications for alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 6, 2009, Pages 519-524

  Evans, Barbara A ^a   Evans, James E ^a   Baker, Stephen P ^c   Kane, Kevin ^b   Swearer, Joan ^b   Hinerfeld, Douglas ^d   Caselli, Richard ^e   Rogaeva, Ekaterina ^f   St George Hyslop, Peter ^f   Moonis, Majaz ^b   Pollen, Daniel A ^b  

^a Proteomics and Mass Spectrometry Facility   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Information Service and Department of Cell Biology   (United States)

^d JACKSON LABORATORY   (United States)

^e MAYO CLINIC   (United States)

^f TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; Brain lipids; Cerebrospinal fluid cholesterol; Statins

Indexed keywords

APOLIPOPROTEIN E4; ATORVASTATIN; CHOLESTEROL; CHOLESTEROL DERIVATIVE; LATHOSTEROL; PRESENILIN 1; SIMVASTATIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CHOLESTEROL CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CHOLESTEROL; FEMALE; HEPTANOIC ACIDS; HETEROZYGOTE; HUMANS; HYDROXYCHOLESTEROLS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUTATION; PILOT PROJECTS; PRESENILIN-1; PYRROLES; SIMVASTATIN;

EID: 66149141822     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000221835     Document Type: Article

References (28)

1. Saunders AM, Strittmatter WJ, Schmechel D, et al:Association of apolipoprotein E allele e 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
2. Notkola IL, Sulkava R, Pekkanen J, et al:Serum total cholesterol, apolipoprotein E ε 4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20.
3. Wolozin B, Kellman W, Ruosseau P, et al:Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-1443.
4. Jick H, Zornberg GL, Jick SS, et al:Statins and the risk of dementia. Lancet 2000;356:1627-1631.
5. Wolozin B, Wang SW, Li NC, et al:Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med 2007;5:20.
6. Sparks DL, Kryscio RJ, Ssabbagh MN, et al:Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res 2008;5:416-421.
7. Shepherd J, Blauw GJ, Murphy MB, et al:Pravastatin in elderly individuals at risk of vascular disease (PROSPER):a randomized controlled trial. Lancet 2002;360:1623-1697.
8. Pollen DA:Hannah's Heirs. The Quest for the Genetic Origins of Alzheimer's Disease. Oxford, Oxford University Press, 1993, pp 1-296.
9. Lippa CF, Saunders AM, Smith TW, et al:Familial and sporadic Alzheimer's disease:neuropathology cannot exclude a final common pathway. Neurology 1996;46:406-412.
10. Hinerfeld DA, Moonis M, Swearer JM, et al: Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects. Arch Neurol 2007;64:1672-1673.
11. Moonis M, Swearer JM, Dayaw MP, et al:Familial Alzheimer disease:decreases in CSF Aβ42 levels precede cognitive decline. Neurology 2005;65:323-325.
12. Dietschy JM, Turley SD:Thematic review series:brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 2004;45:1375-1397.
13. Dzeletovic S, Breuer O, Lund E, et al:Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 1995;225:73-80.
14. Simons M, Schwärzler F, Lütjohann D, et al: Treatment with simvastatin in normocho-lesterolemic patients with Alzheimer disease:a 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 2002;52:346-350.
15. Fassbinder K, Stroick M, Bertsch T, et al:Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology 2002;59:1257-1258.
16. Höglund K, Thelen KM, Syversen S, et al:The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2005;19:256-265.
17. Locatelli S, Lütjohann D, Schmidt HHJ, et al: Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia. Arch Neurol 2002;59:213-216.
18. Vega GL, Weiner MF:Plasma 24S hydroxy-cholesterol response to statins in Alzheimer's disease patients:effects of gender, CYP46, and ApoE polymorphisms. J Mol Neurosci 2007;33:51-55.
19. McLean RA, Sanders WL, Stroup WW: A unified approach to mixed linear models. Am Stat 1991;45:54-64.
20. Singer JD, Willett JB:Applied Longitudinal Data Analysis. Modeling Change and Event Occurrence. Oxford, Oxford University Press, 2003.
21. Verbeke G, Molenberghs G:Linear Mixed Models for Longitudinal Data, ed 1. New York, Springer, 2000.
22. Draper NR, Smith HF:Applied Regression Analysis, ed 2. New York, Wiley &Sons, 1981.
23. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment:a population-based validation study. Neurology 2001;56:37-42.
24. McKhann G, Drachman D, Folstein M, et al:Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
25. Riekse RG, Li G, Petrie EC, et al: Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J Alzheimers Dis 2006;10:399-406.
26. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM:Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 2009;457:1128-1132.
27. Vincent B, Cisse MA, Sunyach C, Guillot-Sestier MW, Cheller F:Regulation of βAPP and PrPc cleavage by α-secretase:mechanistic and therapeutic perspectives. Curr Alzheimer Res 2008;5:202-211.
28. Cisse M, Mucke L:Alzheimer's disease:a prion protein connection. Nature 2009;457:1090-1091.